Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026)
Coherus Oncology's (CHRS) quarterly EPS (Basic) came in at -$0.27 in Q1 2026, up 44.9% year-on-year from -$0.19 in Q1 2025, and up 91.89% quarter-over-quarter from -$3.33 in Q4 2025.
Coherus Oncology (CHRS) EPS (Basic) (2013 - 2026) Analysis & Trends
Coherus Oncology has disclosed EPS (Basic) across 14 years of filings, most recently posting -$0.27 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.27, up 44.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.41 (down 29.36% YoY), and the FY2025 annual result was -$1.56, up 17.02% from the prior year.
- EPS (Basic) came in at -$0.27 for Q1 2026 at Coherus Oncology, up from -$3.33 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.57 in Q2 2025 to a low of -$3.33 in Q4 2025.
- The 5-year median for EPS (Basic) is -$0.49 (2023), against an average of -$0.56.
- Peak annual rise in EPS (Basic) reached 2436.36% in 2025, while the deepest fall reached 732.5% in 2025.
- Coherus Oncology's EPS (Basic) stood at -$0.76 in 2022, then climbed by 2.63% to -$0.74 in 2023, then soared by 45.95% to -$0.4 in 2024, then plunged by 732.5% to -$3.33 in 2025, then jumped by 91.89% to -$0.27 in 2026.
- The last three EPS (Basic) figures came in at -$0.27 (Q1 2026), -$3.33 (Q4 2025), and -$0.38 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Coherus Oncology | 199.14 Mn | 32.09 Mn | 8.50 Mn | -0.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.27 |
| Dec 31, 2025 | -3.33 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | 2.57 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.11 |
| Mar 31, 2024 | -0.60 |
| Dec 31, 2023 | -0.74 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.96 |
| Dec 31, 2022 | -0.76 |
| Sep 30, 2022 | -1.11 |
| Jun 30, 2022 | -0.65 |
| Mar 31, 2022 | -1.24 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.49 |
| Jun 30, 2021 | -0.40 |